Finch Therapeutics Group Inc (FNCH)

Überblick Nachrichten Preisverlauf Financials Forum Prognose Aktiensplit

Finanzdaten der Finch Therapeutics Group Inc-Aktie (FNCH)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	-	-	-	-	0.107
Operating Expenses	17.71% 5.198	4.416	3.781	9.881	67.48
Operating Income/Loss	17.71% -5.198	-4.416	-3.781	-9.881	-67.38
Nonoperating Income/Loss	3.85% 1.322	1.375	1.365	2.931	-0.025
Income/Loss From Continuing Operations Before Tax	27.46% -3.876	-3.041	-2.416	-6.95	-67.40
Income Tax Expense/Benefit, Deferred	-	-	-	-	-3.461
Income Tax Expense/Benefit	-	-	-	-	-3.461
Income/Loss From Continuing Operations After Tax	27.46% -3.876	-3.041	-2.416	-6.95	-62.35
Net Income/Loss	27.46% -3.876	-3.041	-2.416	-6.95	-63.94
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	461.33K% 1.6058	0.000348	1.605	1.6048	48.09
Diluted Average Shares	461.33K% 1.6058	0.000348	1.605	1.6048	48.09
Basic Earnings Per Share	27.51% -2.41	-1.89	-1.51	-4.33	-1.33
Diluted Earnings Per Share	27.51% -2.41	-1.89	-1.51	-4.33	-1.33
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

SMMT

$18.98

3.66%

INCY

$76.97

1.45%

MRNA

$39.51

7.22%

UTHR

$359.21

1.11%

BGNE

$187.69

0.81%

BNTX

$101.87

2.16%

In Yahoo öffnen | In Google öffnen | In Finviz öffnen | In MarketWatch öffnen | Offen in Reuters